Cargando…
An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
Results from the Women's Health Initiative (WHI) trial support findings from observational studies that oestrogen–progestin therapy (EPT) use is associated with an increase in breast cancer risk. We conducted a meta-analysis using EPT-specific results from the Collaborative Group on Hormonal Fa...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361783/ https://www.ncbi.nlm.nih.gov/pubmed/15900297 http://dx.doi.org/10.1038/sj.bjc.6602617 |